Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,552 | 69 | 1,882 | 2,624 | 3,525 |
| Marketable Securities | N/A | 975 | N/A | N/A | N/A |
| Receivables | 92 | 109 | 75 | 47 | 25 |
| TOTAL | $2,700 | $1,226 | $2,072 | $2,796 | $3,640 |
| Non-Current Assets | |||||
| PPE Net | 28 | 36 | 44 | 52 | 60 |
| Investments And Advances | 1,513 | 0 | 0 | 0 | 0 |
| TOTAL | $1,540 | $36 | $44 | $52 | $60 |
| Total Assets | $4,241 | $1,261 | $2,115 | $2,847 | $3,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,098 | 874 | 2,068 | 1,910 | 2,085 |
| Accrued Expenses | 2,351 | 78 | 78 | 78 | 78 |
| TOTAL | $5,247 | $2,842 | $3,583 | $3,425 | $3,600 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,345 | 1,437 | 1,437 | 1,437 | 1,437 |
| Other Non-Current Liabilities | 0 | 2,273 | 0 | 0 | 0 |
| TOTAL | $2,837 | $5,155 | $3,241 | $3,625 | $3,985 |
| Total Liabilities | $8,085 | $7,997 | $6,824 | $7,050 | $7,585 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,726 | 5,723 | 5,330 | 5,316 | 5,316 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -10,637 | -10,173 | -7,938 | -7,192 | -6,714 |
| Other shareholders' equity | 94 | -320 | -320 | -320 | -320 |
| TOTAL | $-3,844 | $-6,736 | $-4,709 | $-4,203 | $-3,885 |
| Total Liabilities And Equity | $4,241 | $1,261 | $2,115 | $2,847 | $3,700 |